HARCP

HEROIN ADDICTION AND
RELATED CLINICAL PROBLEMS

The official journal of
EUROPAD - European Opiate Addiction Treatment Association
WFTOD - World Federation for the Treatment of Opioid Dependence
Editor: Icro Maremmani, MD - Pisa, Italy, EU
Associate Editors:
Thomas Clausen, MD - Oslo, Norway
Pier Paolo Pani, MD - Cagliari, Italy, EU
Marta Torrens, MD - Barcelona, Spain, EU
Statistical Editor:
Mario Miccoli, PhD - Pisa, Italy, EU

HARCP Archives

Browse by article Browse by volume    

Heroin Addiction and Related Clinical Problems: 2005, 07, 4 (pages: 31 - 42)

Psychopathological disorders in heroin addicts and administration of risperidone during rehabilitation

Kozlov A. A., Dorovskih I. V., Doljanskaia N. A., Buzina T. S., Polunina A. G.

Summary: The topic of the present study is the clinical picture of psychopathological symptoms during post-withdrawal periods in heroin addicts. Craving symptoms can be compared to productive psychopathological symptoms, and their intensity usually corresponds to the severity of depressive disorders in heroin ex-addicts. Risperidone is therefore a preferred choice for craving control when opiate maintenance therapy is unavailable (as it is currently in Russia). This antipsychotic showed its effectiveness and safety during prolonged anti-relapse therapy in the out-patient treatment of heroin addicts.

 

EUROPAD - European Opiate Addiction Treatment Association
Brussels, Belgium, EU
P. IVA 01681650469 – Codice Fiscale 94002580465 Reserved Area
Tel/Phone: 0584 - 790073 - Email: info@heroinaddictionrelatedclinicalproblems.org
Start of page